Literature DB >> 22414416

Postoperative pulmonary complications: pneumonia and acute respiratory failure.

Gaurav Sachdev1, Lena M Napolitano.   

Abstract

Postoperative pulmonary complications (atelectasis, pneumonia, pulmonary edema, acute respiratory failure) are common, particularly after abdominal and thoracic surgery, pneumonia and atelectasis being the most common. Postoperative pneumonia is associated with increased morbidity, length of hospital stay, and costs. Few institutions have pneumonia prevention programs for surgical patients, and these should be strongly considered. Acute respiratory failure is a life-threatening pulmonary complication that requires institution of mechanical ventilation and admission to the intensive care unit, and is associated with increased risk for ventilator-associated pneumonia. This article discusses epidemiology, risk factors, diagnosis, treatment, and prevention of these pulmonary complications in surgical patients. Copyright Â
© 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22414416     DOI: 10.1016/j.suc.2012.01.013

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  21 in total

Review 1.  Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases?

Authors:  John Heineman; Sara Bubenik; Stephen McClave; Robert Martindale
Journal:  Curr Gastroenterol Rep       Date:  2012-08

2.  Risk factors for 30-day hospital readmission among general surgery patients.

Authors:  Michael T Kassin; Rachel M Owen; Sebastian D Perez; Ira Leeds; James C Cox; Kurt Schnier; Vjollca Sadiraj; John F Sweeney
Journal:  J Am Coll Surg       Date:  2012-06-21       Impact factor: 6.113

3.  Penetrating torso injuries in older adults: increased mortality likely due to "failure to rescue".

Authors:  S R Allen; D R Scantling; M K Delgado; J Mancini; D N Holena; P Kim; J L Pascual; P Reilly
Journal:  Eur J Trauma Emerg Surg       Date:  2015-01-08       Impact factor: 3.693

Review 4.  Bugs or drugs: are probiotics safe for use in the critically ill?

Authors:  Lindsay M Urben; Jennifer Wiedmar; Erica Boettcher; Rodrigo Cavallazzi; Robert G Martindale; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2014

5.  Results of surgery in general surgical patients receiving warfarin: retrospective analysis of 61 patients.

Authors:  Sedat Belli; Huseyin Ozgur Aytac; Hakan Yabanoglu; Erdal Karagulle; Alper Parlakgumus; Tarik Zafer Nursal; Sedat Yildirim
Journal:  Int Surg       Date:  2015-02

6.  Effect of sigh in lateral position on postoperative atelectasis in adults assessed by lung ultrasound: a randomized, controlled trial.

Authors:  Caifeng Li; Qian Ren; Xin Li; Hongqiu Han; Min Peng; Keliang Xie; Zhiqiang Wang; Guolin Wang
Journal:  BMC Anesthesiol       Date:  2022-07-11       Impact factor: 2.376

7.  The impact of adverse events on health care costs for older adults undergoing nonelective abdominal surgery.

Authors:  Jonathan G Bailey; Philip J B Davis; Adrian R Levy; Michele Molinari; Paul M Johnson
Journal:  Can J Surg       Date:  2016-06       Impact factor: 2.089

8.  Patients over 70 years of age with moderate ischemic mitral regurgitation undergoing surgical revascularization plus mitral valve repair: insights from a single-center study of propensity-matched data.

Authors:  Qiang Ji; Xiao-Min Qi; Jin-Qiang Shen; Yu-Lin Wang; Ye Yang; Wen-Jun Ding; Li-Min Xia; Chun-Sheng Wang
Journal:  Cardiovasc Diagn Ther       Date:  2019-12

9.  Respiratory muscle training in patients recovering recent open cardiothoracic surgery: a randomized-controlled trial.

Authors:  Ernesto Crisafulli; Elena Venturelli; Gherardo Siscaro; Fabio Florini; Alessandra Papetti; Daniela Lugli; Massimo Cerulli; Enrico Clini
Journal:  Biomed Res Int       Date:  2013-07-30       Impact factor: 3.411

10.  Risk factors for pulmonary complications following cardiac surgery with cardiopulmonary bypass.

Authors:  Qiang Ji; Yunqing Mei; Xisheng Wang; Jing Feng; Jianzhi Cai; Wenjun Ding
Journal:  Int J Med Sci       Date:  2013-09-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.